Regen BioPharma Inc
(OTCPK:RGBP)
$
0.28
0.07459 (36.31%)
Market Cap: 1.26 Mil
Enterprise Value: 1.58 Mil
PE Ratio: 0
PB Ratio: 0
GF Score: 35/100 Regen BioPharma Inc At Emerging Growth Conference Transcript
Nov 30, 2022 / 06:45PM GMT
Release Date Price:
$7.42
(-8.33%)
Ana Berry
Emerging Growth Conference - Analyst
Welcome back, everyone. Next up, we have a Regen BioPharma Inc. It trades on the OTC under the symbol, RGBP. And it's focused currently on mRNA and small molecule therapies for treating cancer and autoimmune disorders. Please welcome its President and CEO, David Koos, and Senior Scientific Consultant, Harry Lander.
Welcome back, gentlemen, how are you doing?
David Koos
Regen BioPharma Inc. - CEO
Really good. Glad to see you.
Harry Lander
Regen BioPharma Inc. - Senior Scientific Consultant
Thanks for having us.
Ana Berry
Emerging Growth Conference - Analyst
All right. Take it away.
David Koos
Regen BioPharma Inc. - CEO
Okay. So today's presentation really a follow-up to our first presentation. We have received quite a few questions that have popped up since the first presentation so much so that we have an abundance of items. And the goal here today is to really
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot